NCT01680887View on ClinicalTrials.gov

A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2018

Study Completion Date

June 30, 2019

Conditions
Cocaine Dependence
Interventions
DRUG

Varenicline

DRUG

Placebo

Trial Locations (1)

19104

University of Pennsylvania Treatment Research Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01680887 - A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence | Biotech Hunter | Biotech Hunter